Navigation Links
OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
Date:7/20/2009

sed financing and the company's manufacturing readiness, prospects for securing a co-development and commercialization partner and planned phase 3 trials. Such forward-looking statements are subject to risks and uncertainties, including, among others: the satisfaction of certain closing conditions in respect of the financing; and the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for fiscal year 2008. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. OncoGenex Pharmaceuticals Added to Russell Indexes
2. OncoGenex Pharmaceuticals Files Shelf Registration Statement
3. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
4. OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
5. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
6. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
7. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
8. OncoGenex Pharmaceuticals Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting
9. OncoGenex Reports First Quarter Financial Results
10. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
11. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25/PRNewswire/--BiotechfirmReplikinsLtd.,whichhasa...throughtheprediction,outbreak,andprogressofthecurr...lysisofthevirus.Thenewdatashowsthatthelethalityoft...s.d.4.5)duringthevirus,scurrentoutbreakinthespring....0.1).TheH1N1virus,infectivitycount,however,remain...
(Date:11/25/2009)...CARATON,Fla.,Nov.25/PRNewswire/--Formanybusinesses...tion,slargestandfastestgrowingnetworkofexpertphysi...bioidenticalhormones has grownthenumberof physic...sicians -andisinprogresstoaddmorephysician-ownedce... ,, Inthepastyear ,BodyLogicMDhasopened13newbio...
(Date:11/25/2009)....25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),ale...thatitexecuted,ajointventure(JV)agreementtoestabli...cDalian).TheJVwillresearch,develop,produce,andcomm...sexpertise,andexperienceindevelopingandcommerciali...landuserights,manufacturingfacilitiesand,establish...
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--ArdeaBiosciences,Inc.(....D.,presidentandchiefexecutiveofficer,willpresenta...,Presentationdetailsareasfollows:,PiperJaffray21...1,2009,Time:2:00p.m.EasternTime,Location:TheNewYor....corporate-ir.net/ireye/,target=,_blank,title=,ht...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...AU CLAIRE, Wis.AT&T announced Tuesday it has won a...ation Services, Inc., renewing an agreement for to...s services. These services enable KRM to provide t...e virtual seminars to associations, publishers, co...based KRM manages live audio and Web-based visual ...
...ILWAUKEE Merge eFilm announced Tuesday it has a...e purchase of up to $10 million of common stock. P...d the timing, price and volume of repurchases will...ies laws and other factors. , ,"We continue to exp...reholder value, while simultaneously generating po...
...LOOMFIELD HILLS, Mich. Logicalis , an internatio... Unix and storage solution providers, announced Mo... privately held IBM solution provider and one of I...S. headquarters are located in Michigan, also exec...solution provider. , ,Logicalis, goal is and has a...
Other Biology Technology:Logicalis purchases Solution Technology for $90M 2
(Date:11/25/2009)...ime, the heart pumps some 250 million liters of bl... muscle fibers of the heart have to be extremely d...Rottbauer, vice chair of the Department of Medicin... Prof. Dr. H. A. Katus), has discovered a protein ...est muscular unit, the sarcomere. In cooperation w...
(Date:11/24/2009)...new doors to understanding how sounds associated w...e mammal or if they hear it at all. , The same ... NASA uses to detect flaws in the space shuttle,s ...ists to peek inside the giant head of a whale. The...plicas of a whale,s hearing anatomy using a breakt...
(Date:11/24/2009)...November 24, 2009) -- The Wildlife Conservation So...t the last remaining population of Siberian tigers...ng tide of poaching and habitat loss. , ...fficials of what needs to be done to protect remai... The report was released by the Siberia...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 1Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 2Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 3Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 4World first 3A Chinese scientists create pig stem cells 47717 1World first 3A Chinese scientists create pig stem cells 47717 2World first 3A Chinese scientists create pig stem cells 47717 3Upcoming Investor Events at The American Association for Clinical Chemistry 28AACC 29 Annual Meeting 26 Clinical Lab Exposition 47712 1Upcoming Investor Events at The American Association for Clinical Chemistry 28AACC 29 Annual Meeting 26 Clinical Lab Exposition 47712 2
...07 In a paper published today in the journal Scie... and academic colleagues from the National Univers...n Sweden report the discovery of two common single...uman genome that appear to account for virtually a...are located in the LOXL1 gene on chromosome 15, an...
...cer therapy by blocking the molecular motors invol...ision is being pursued by young Dutch researcher D...inning projects sponsored by the European Science ...h Councils (EuroHORCS). Dekker and her team are t...h the molecular motors that copy DNA during cell d...
..., researchers report for the first time that genet...ures harboring DNA that are inherited only from th...or type 2 diabetes. The study, which highlights t...athogenesis of common diseases, is published onlin...rding to the Centers for Disease Control, 7% of th...
Other Biology News:deCODE discovers cause of major subtype of glaucoma 2ESF EURYI award winner aims to stop cancer cells reading their own DNA 2Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes 2
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Nutrient Mixture F-12 Ham, Coon's Modification (Ham's F-12 Coon's) from Sigma-Aldrich
... solution. It is routinely used as an anticoagulan... whole blood at refrigerator temperatures for appr... blood is collected into a container of this produ... is placed in a refrigerator at 2-8 C for 2 weeks....
...igh throughput synthesis are new and unique resour...products provide a large number (from hundreds and...n a microtube as a mixture or in multiple microtub.... This is a custom product so RNA sequences and le...
Biology Products: